• Latest Posts

Treatment for patients with fragile skin disease accepted by FDA

Almirall launches new call to find innovative therapies for skin diseases

Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment

Is Novartis’ Psoriasis Drug Going to Steal Humira’s Crown?

This Belgian Biotech Gives Us an Update on its Bulging Psoriasis Pipeline

Janssen’s Psoriasis Drug is Given a Thumbs Up for Use in Europe

In Depth 17 Oct 2017

Blockbuster Potential: How Biotech is Paving the Way to Clear Skin from Psoriasis

Update: After 25 years, MorphoSys Gets its First Antibody Approved

Update: Danish Psoriasis Drug Gets EU Approval Despite Suicide Links

Interview 4 May 2017

This Belgian Startup is building the Next Generation of Diagnostic Tests

Merck Outsources the Development of its Nanobody for Psoriasis